NBTY Announces Preliminary Unaudited Fourth Quarter and Year End Net Sales Results
04 Ottobre 2004 - 2:00PM
PR Newswire (US)
NBTY Announces Preliminary Unaudited Fourth Quarter and Year End
Net Sales Results BOHEMIA, N.Y., Oct. 4 /PRNewswire-FirstCall/ --
NBTY, Inc. (NYSE:NTY) (http://www.nbty.com/), a leading
manufacturer and marketer of nutritional supplements, today
announced preliminary unaudited net sales results for the fiscal
fourth quarter and fiscal year ended September 30, 2004. The
following is a comparison of the preliminary unaudited net sales
results by segment: (Millions) THREE MONTHS ENDED FISCAL YEARS
ENDED SEPTEMBER 30, SEPTEMBER 30, 2004 2003 % Increase/ 2004 2003 %
Increase (Unaudited)(Unaudited)(Decrease) (Unaud-(Audited) ited)
Wholesale $193 $164 18% $733 $417 76% US Retail/ Vitamin World 53
54 (2%) 216 212 2% European Retail/ Holland & Barrett/ GNC 133
95 40% 495 364 36% Direct Response/ Puritan's Pride 47 52 (9%) 206
200 3% Total $426 $ 365 17% $1,650 $1,193 38% NBTY expects to
announce its audited results for fiscal year 2004 in mid- November.
ABOUT NBTY NBTY is a leading vertically integrated manufacturer and
distributor of a broad line of high-quality, value-priced
nutritional supplements in the United States and throughout the
world. The Company markets approximately 1,500 products under
several brands, including Nature's Bounty(R), Vitamin World(R),
Puritan's Pride(R), Holland & Barrett(R), Rexall(R),
Sundown(R), MET-Rx(R), WORLDWIDE Sport Nutrition(R), American
Health(R), GNC (UK)(R) and DeTuinen(R). This release contains
certain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995 with respect to
our financial condition, results of operations and business. All of
these forward-looking statements, which can be identified by the
use of terminology such as "subject to," "believe," "expects,"
"may," "will," "should," "can," or "anticipates," or the negative
thereof, or variations thereon, or comparable terminology, or by
discussions of strategy which, although believed to be reasonable,
are inherently uncertain. Factors which may materially affect such
forward-looking statements include: (i) slow or negative growth in
the nutritional supplement industry; (ii) interruption of business
or negative impact on sales and earnings due to acts of war,
terrorism, bio-terrorism, civil unrest or disruption of mail
service; (iii) adverse publicity regarding nutritional supplements;
(iv) inability to retain customers of companies (or mailing lists)
recently acquired; (v) increased competition; (vi) increased costs;
(vii) loss or retirement of key members of management; (viii)
increases in the cost of borrowings and unavailability of
additional debt or equity capital; (ix) unavailability of, or
inability to consummate, advantageous acquisitions in the future,
including those that may be subject to bankruptcy approval or the
inability of NBTY to integrate acquisitions into the mainstream of
its business; (x) changes in general worldwide economic and
political conditions in the markets in which NBTY may compete from
time to time; (xi) the inability of NBTY to gain and/or hold market
share of its wholesale and/or retail customers anywhere in the
world; (xii) unavailability of electricity in certain geographical
areas; (xiii) the inability of NBTY to obtain and/or renew
insurance; (xiv) exposure to and expense of defending and
resolving, product liability claims and other litigation; (xv) the
ability of NBTY to successfully implement its business strategy;
(xvi) the inability of NBTY to manage its retail, wholesale,
manufacturing and other operations efficiently; (xvii) consumer
acceptance of NBTY's products; (xviii) the inability of NBTY to
renew leases on its retail locations; (xix) inability of NBTY's
retail stores to attain or maintain profitability; (xx) the absence
of clinical trials for many of NBTY's products; (xxi) sales and
earnings volatility and/or trends; (xxii) the efficacy of NBTY's
Internet and on-line sales and marketing; (xxiii) fluctuations in
foreign currencies, including the British Pound; (xxiv)
import-export controls on sales to foreign countries; (xxv) the
inability of NBTY to secure favorable new sites for, and delays in
opening, new retail locations; (xxvi) introduction of new federal,
state, local or foreign legislation or regulation or adverse
determinations by regulators anywhere in the world (including the
banning of products) and more particularly the Food Supplements
Directive and the Traditional Herbal Medicinal Products Directive
in Europe; (xxvii) the mix of NBTY's products and the profit
margins thereon; (xxviii) the availability and pricing of raw
materials; (xxix) risk factors discussed in NBTY's filings with the
U.S. Securities and Exchange Commission; (xxx) adverse effects on
NBTY as a result of increased gasoline prices and potentially
reduced traffic flow to NBTY's retail locations; and (xxxi) other
factors beyond NBTY's control. Readers are cautioned not to place
undue reliance on forward-looking statements. NBTY cannot guarantee
future results, trends, events, levels of activity, performance or
achievements. NBTY does not undertake and specifically declines any
obligation to update, republish or revise forward- looking
statements to reflect events or circumstances after the date hereof
or to reflect the occurrences of unanticipated events. DATASOURCE:
NBTY, Inc. CONTACT: Harvey Kamil of NBTY, Inc., President and Chief
Financial Officer, +1-631-244-2020; or Carl Hymans, G.S. Schwartz
& Co., +1-212-725-4500, Web site: http://www.nbty.com/
Copyright
Grafico Azioni N B T Y (NYSE:NTY)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni N B T Y (NYSE:NTY)
Storico
Da Lug 2023 a Lug 2024